 | | | | Senior citizens who received a second booster of the Pfizer–BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only, a study from Israel showed on Sunday. | | | | | | Canadian vaccine maker Medicago's COVID-19 vaccine, approved last month in Canada, is facing limited growth in the near-term after the World Health Organization said it would not review the vaccine because the company is partly owned by U.S.-Swiss tobacco company Philip Morris, health experts say. | | | | | | Hong Kong reported 8,037 new COVID-19 infections on Sunday and 151 deaths, the second day in a row below 10,000 cases, as the global financial hub gradually starts to open up, with the government announcing an easing of restrictions from April. | | | | | | China's financial hub of Shanghai said on Sunday it would lock down the city in two stages to carry out COVID-19 testing over a nine-day period, after it reported a new daily record for asymptomatic infections. | | | | | | Hong Kong reported 8,841 new cases of COVID-19 on Saturday, down from 10,405 on Friday, as its latest wave of infections continues to ease. | | | | | | China reported 1,335 confirmed coronavirus cases for March 25, the country's national health authority said on Saturday, compared with 1,366 a day earlier. | | | | | | Nearly a year after COVID vaccines became freely available in the U.S., one fourth of American adults remain unvaccinated, and a picture of the economic cost of vaccine hesitancy is emerging. | | | | | | The U.S. health regulator said on Friday the current authorized dose of GlaxoSmithKline and Vir Biotechnology's COVID-19 antibody therapy is unlikely to be effective against the Omicron BA.2 variant. | | | | | | After producing vaccines and treatments for acute COVID-19 in record time, researchers and drugmakers are turning to finding a cure for long COVID, a more elusive target marked by hundreds of different symptoms afflicting millions of people. | | | | | |
